First Time Loading...
A

Akoya Biosciences Inc
NASDAQ:AKYA

Watchlist Manager
Akoya Biosciences Inc
NASDAQ:AKYA
Watchlist
Price: 3.81 USD Market Closed
Updated: Apr 25, 2024

Intrinsic Value

AKYA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. [ Read More ]

The intrinsic value of one AKYA stock under the Base Case scenario is 15.34 USD. Compared to the current market price of 3.81 USD, Akoya Biosciences Inc is Undervalued by 75%.

Key Points:
AKYA Intrinsic Value
Base Case
15.34 USD
Undervaluation 75%
Intrinsic Value
Price
A
Base Case Scenario

Valuation Backtest
Akoya Biosciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AKYA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Akoya Biosciences Inc

Provide an overview of the primary business activities
of Akoya Biosciences Inc.

What unique competitive advantages
does Akoya Biosciences Inc hold over its rivals?

What risks and challenges
does Akoya Biosciences Inc face in the near future?

Has there been any significant insider trading activity
in Akoya Biosciences Inc recently?

Summarize the latest earnings call
of Akoya Biosciences Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Akoya Biosciences Inc.

Provide P/S
for Akoya Biosciences Inc.

Provide P/E
for Akoya Biosciences Inc.

Provide P/OCF
for Akoya Biosciences Inc.

Provide P/FCFE
for Akoya Biosciences Inc.

Provide P/B
for Akoya Biosciences Inc.

Provide EV/S
for Akoya Biosciences Inc.

Provide EV/GP
for Akoya Biosciences Inc.

Provide EV/EBITDA
for Akoya Biosciences Inc.

Provide EV/EBIT
for Akoya Biosciences Inc.

Provide EV/OCF
for Akoya Biosciences Inc.

Provide EV/FCFF
for Akoya Biosciences Inc.

Provide EV/IC
for Akoya Biosciences Inc.

Show me price targets
for Akoya Biosciences Inc made by professional analysts.

What are the Revenue projections
for Akoya Biosciences Inc?

How accurate were the past Revenue estimates
for Akoya Biosciences Inc?

What are the Net Income projections
for Akoya Biosciences Inc?

How accurate were the past Net Income estimates
for Akoya Biosciences Inc?

What are the EPS projections
for Akoya Biosciences Inc?

How accurate were the past EPS estimates
for Akoya Biosciences Inc?

What are the EBIT projections
for Akoya Biosciences Inc?

How accurate were the past EBIT estimates
for Akoya Biosciences Inc?

Compare the revenue forecasts
for Akoya Biosciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Akoya Biosciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Akoya Biosciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Akoya Biosciences Inc compared to its peers.

Compare the P/E ratios
of Akoya Biosciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Akoya Biosciences Inc with its peers.

Analyze the financial leverage
of Akoya Biosciences Inc compared to its main competitors.

Show all profitability ratios
for Akoya Biosciences Inc.

Provide ROE
for Akoya Biosciences Inc.

Provide ROA
for Akoya Biosciences Inc.

Provide ROIC
for Akoya Biosciences Inc.

Provide ROCE
for Akoya Biosciences Inc.

Provide Gross Margin
for Akoya Biosciences Inc.

Provide Operating Margin
for Akoya Biosciences Inc.

Provide Net Margin
for Akoya Biosciences Inc.

Provide FCF Margin
for Akoya Biosciences Inc.

Show all solvency ratios
for Akoya Biosciences Inc.

Provide D/E Ratio
for Akoya Biosciences Inc.

Provide D/A Ratio
for Akoya Biosciences Inc.

Provide Interest Coverage Ratio
for Akoya Biosciences Inc.

Provide Altman Z-Score Ratio
for Akoya Biosciences Inc.

Provide Quick Ratio
for Akoya Biosciences Inc.

Provide Current Ratio
for Akoya Biosciences Inc.

Provide Cash Ratio
for Akoya Biosciences Inc.

What is the historical Revenue growth
over the last 5 years for Akoya Biosciences Inc?

What is the historical Net Income growth
over the last 5 years for Akoya Biosciences Inc?

What is the current Free Cash Flow
of Akoya Biosciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Akoya Biosciences Inc.

Financials

Balance Sheet Decomposition
Akoya Biosciences Inc

Current Assets 121.8m
Cash & Short-Term Investments 83.1m
Receivables 17m
Other Current Assets 21.7m
Non-Current Assets 58.6m
PP&E 21.5m
Intangibles 35.7m
Other Non-Current Assets 1.4m
Current Liabilities 35.3m
Accounts Payable 11.8m
Accrued Liabilities 13.1m
Other Current Liabilities 10.5m
Non-Current Liabilities 91.3m
Long-Term Debt 76m
Other Non-Current Liabilities 15.2m
Efficiency

Earnings Waterfall
Akoya Biosciences Inc

Revenue
96.6m USD
Cost of Revenue
-40.3m USD
Gross Profit
56.3m USD
Operating Expenses
-114m USD
Operating Income
-57.7m USD
Other Expenses
-5.7m USD
Net Income
-63.3m USD

Free Cash Flow Analysis
Akoya Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

AKYA Profitability Score
Profitability Due Diligence

Akoya Biosciences Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROE is Increasing
Positive Revenue Growth Forecast
28/100
Profitability
Score

Akoya Biosciences Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

AKYA Solvency Score
Solvency Due Diligence

Akoya Biosciences Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
35/100
Solvency
Score

Akoya Biosciences Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AKYA Price Targets Summary
Akoya Biosciences Inc

Wall Street analysts forecast AKYA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AKYA is 9.01 USD with a low forecast of 7.07 USD and a high forecast of 11.55 USD.

Lowest
Price Target
7.07 USD
86% Upside
Average
Price Target
9.01 USD
136% Upside
Highest
Price Target
11.55 USD
203% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

AKYA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

AKYA Price
Akoya Biosciences Inc

1M 1M
-23%
6M 6M
+11%
1Y 1Y
-43%
3Y 3Y
-83%
5Y 5Y
-81%
10Y 10Y
-81%
Annual Price Range
3.81
52w Low
3.13
52w High
8.35
Price Metrics
Average Annual Return -31.48%
Standard Deviation of Annual Returns 8.95%
Max Drawdown -88%
Shares Statistics
Market Capitalization 187.1m USD
Shares Outstanding 49 140 700
Percentage of Shares Shorted 3.14%

AKYA Return Decomposition
Main factors of price return

What is price return decomposition?

AKYA News

Other Videos

Company Profile

Akoya Biosciences Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

187.1m USD

Dividend Yield

0%

Description

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and currently employs 319 full-time employees. The company went IPO on 2021-04-16. The firm deliveries spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platform, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. The company provides PhenoImager HT, which is a digital pathology slide scanner featuring MOTiF whole-slide multispectral scanning of up to seven biomarkers with an 80-slide capacity. The company offers contract research services laboratory, which is called as advanced biopharma solutions.

Contact

MASSACHUSETTS
Marlborough
100 Campus Drive, 6Th Floor
+18558968401.0
https://www.akoyabio.com/

IPO

2021-04-16

Employees

319

Officers

President, CEO & Director
Mr. Brian McKelligon
CFO, Principal Financial Officer & Principal Accounting Officer
Mr. John Frederick Ek
Chief Operating Officer
Dr. Frederic G. Pla Ph.D.
Senior Director of Business Development & Investor Relations Strategy
Priyam Shah
General Counsel
Ms. Jennifer Kamocsay
Chief Business Officer
Dr. Niro Ramachandran Ph.D.
Show More
Senior Vice President, Research & Development and Laboratory Operations
Dr. Pascal Bamford Ph.D.
Secretary
Mr. Rob C. Hart CFA, J.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one AKYA stock?

The intrinsic value of one AKYA stock under the Base Case scenario is 15.34 USD.

Is AKYA stock undervalued or overvalued?

Compared to the current market price of 3.81 USD, Akoya Biosciences Inc is Undervalued by 75%.